Serial 79331641
Live / Registered — Registered (as of 20 Jun 2023)
What this means for you
Registered since 20 Jun 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79331641
- Registration number
- 7082543
- Mark type
- Design / logo
- Filed
- 09 Dec 2021
- Published for opposition
- 04 Apr 2023
- Registered
- 20 Jun 2023
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, pharmaceutical preparations to treat neurodegenerative diseases; pharmaceuticals, namely, pharmaceutical preparations to attenuate the accumulation of dysfunctional proteins
- Class 042 — Scientific and technological services: Scientific research services; medical research services; pharmaceutical research and development services; scientific research in the nature of conducting clinical trials in the field of neurodegenerative diseases; scientific research in the nature of conducting clinical trials in the field of dysfunctional protein accumulation; research and development in the field of biotechnology; research and development in the field of biochemistry; information, advisory and consultancy services in relation to all of the foregoing
Owner
Prosecution history
- 10 Oct 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 21 Sept 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 21 Sept 2023 — FINAL DISPOSITION PROCESSED
- 20 Sept 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 20 Jun 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Jun 2023 — REGISTERED-PRINCIPAL REGISTER
- 05 Apr 2023 — NOTIFICATION PROCESSED BY IB
- 04 Apr 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Apr 2023 — PUBLISHED FOR OPPOSITION
- 15 Mar 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 15 Mar 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 15 Mar 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Feb 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Feb 2023 — DATA MODIFICATION COMPLETED
- 21 Feb 2023 — ASSIGNED TO LIE